SCHEMBL30879162

SCHEMBL30879162

COc1cc(N(C)CCN(C)C)ccc1Nc1ncc2c(C#C[Si](C(C)C)(C(C)C)C(C)C)c(-c3ccccc3Cl)c(=O)n(C)c2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 10/20 0.48
BTK Q06187 3/20 0.48
FGFR1 P11362 4/20 0.45
JAK3 P52333 1/20 0.44
WEE1 P30291 3/20 0.42
IGF1R P08069 5/20 0.41
ROS1 P08922 2/20 0.41
ALK Q9UM73 2/20 0.41
MET P08581 1/20 0.41
CDK4 P11802 1/20 0.41
FGFR2 P21802 1/20 0.41
FGFR4 P22455 1/20 0.41
FGFR3 P22607 1/20 0.41
KCNH2 Q12809 2/20 0.39
MAPK7 Q13164 1/20 0.38
LRRK2 Q5S007 1/20 0.38
INSR P06213 2/20 0.38
ERBB2 P04626 1/20 0.38
FER P16591 1/20 0.38
LTK P29376 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30878727 0.91 EGFR (0.50) EGFRBTKFGFR1JAK3IGF1R
SCHEMBL30878436 0.90 EGFR (0.49) EGFRBTKFGFR1JAK3WEE1
SCHEMBL30879233 0.88 WEE1 (0.52) EGFRFGFR1WEE1CDK4FGFR2
SCHEMBL30878805 0.87 EGFR (0.56) EGFRBTKFGFR1WEE1IGF1R
SCHEMBL30879218 0.85 EGFR (0.49) EGFRBTKFGFR1JAK3IGF1R
SCHEMBL30878690 0.85 FGFR4 (0.43) EGFRBTKFGFR1JAK3WEE1
SCHEMBL30879105 0.84 FGFR1 (0.46) EGFRBTKFGFR1JAK3WEE1
SCHEMBL30878685 0.83 IGF1R (0.54) EGFRIGF1RALKMAPK7LRRK2
SCHEMBL30878822 0.82 EGFR (0.49) EGFRBTKFGFR1JAK3IGF1R
SCHEMBL30878665 0.82 WEE1 (0.49) EGFRFGFR1WEE1FGFR2FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed